Nurse willing to go to court over unpaid parking fine at hospital derbytelegraph.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from derbytelegraph.co.uk Daily Mail and Mail on Sunday newspapers.
+Undoctored
Media release from the Breast Cancer Foundation NZ
Thursday 18 February 2021, 01:58 PM
1 minute to Read
Ahead of New Zealand’s roll-out of the COVID-19 vaccine, Breast Cancer Foundation NZ is urging Kiwi women not to delay their mammograms. This comes as reports out of the United States suggest a possible side effect of the vaccine may mimic breast cancer symptoms.
The Society of Breast Imaging, a US-based non-profit organisation, has cited data showing about 12-16% of patients receiving either Moderna or Pfizer vaccines developed swollen lymph nodes in the armpit or neck. This occurred within a week of vaccination and affected the same side as the arm that was injected. Swollen axillary (armpit) nodes can be seen on mammogram and be mistaken as a sign of breast cancer. Based on these findings, the US organisation is recommending women have their mammograms before receiving the first dose of the COVID-19 vaccine, or wait four to six weeks after their seco
Press release content from PR Newswire. The AP news staff was not involved in its creation.
SmartBreast™ Acquires Molecular Breast Imaging Assets from GE Healthcare
February 8, 2021 GMT
PITTSBURGH, Feb. 8, 2021 /PRNewswire/ SmartBreast Corporation (SmartBreast™), a privately held company focused on breast cancer screening and diagnosis, announced today that it has acquired the Discovery NM750b Molecular Breast Imaging (MBI) assets from GE Healthcare, including the MBI scanner designs, manufacturing tools, instructions, related patents and the installed-base service business.
The Discovery NM750b is installed at scores of sites worldwide. SmartBreast will manufacture, market and distribute the MBI scanner, rebranded as “EVE CLEAR SCAN e750.”